In this interview with CEOCFO Magazine, Dr. John M. Burke, Co-founder, President and CEO of Applied BioMath discusses how Applied BioMath is focused on growing its team of industry leaders to better meet the needs of their biotech and pharma customers using mathematical modeling to de-risk and accelerate drug development. "Our growth plays a role in our brand recognition. Several of our most recent hires, including Alison Betts and Helen Moore, from Pfizer and AstraZeneca, respectively, are leaders in our industry," said Dr. John M. Burke. "The fact that they came to work for us says a lot about their belief in our brand and value. We’ve also increased our brand awareness through advertising on local NPR stations, presenting at scientific conferences, and hosting our own events."

Leave this site and view article >>